Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves

Brain Research

Volumn 1227, Issue , 2008, Pages 216-220

  Yoshino, Hiide ^a   Ariga, Toshio ^b   Suzuki, Akemi ^c   Yu, Robert K ^b   Miyatake, Tadashi ^c  

^a 1 7 1 Kohnodai   (Japan)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c Japan Science and Technology Agency   (Japan)

Author keywords

GalNAc GD1a; Guillain Barr syndrome; Motor neuron; Spinal nerve root

Indexed keywords

2 DIETHYLAMINOETHANOL; DISIALOGANGLIOSIDE DERIVATIVE; GANGLIOSIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; N ACETYLGALACTOSAMINE; N ACETYLGALACTOSAMINYL GD1A ANTIBODY; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID; SEPHADEX; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; COLUMN CHROMATOGRAPHY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOTONEURON; MOTOR NERVE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPINAL CORD NERVE CELL; TAY SACHS DISEASE; THIN LAYER CHROMATOGRAPHY;

ANIMALS; AUTOANTIBODIES; CATTLE; CHROMATOGRAPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEAE-DEXTRAN; G(M1) GANGLIOSIDE; G(M2) GANGLIOSIDE; G(M3) GANGLIOSIDE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; MOTOR NEURONS; PERIPHERAL NERVES; SPINAL CORD;

BOVINAE;

EID: 48949107097     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.06.020     Document Type: Article

References (20)

1. Ando S., Chang N.C., and Yu R.K. High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species. Anal. Biochem. 89 (1978) 437-450
2. Ang C.W., Yuki N., Jacobs B.C., Koga M., van Doorn P.A., Schmitz P.I.M., and Van Der Meché F.G.A. Rapidly progressive predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies. Neurology 53 (1999) 2122-2127
3. Ariga T., and Yu R.K. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases; review of clinical features and antibody specificities. J. Neurosci. Res. 80 (2005) 1-17
4. 4Cer, from bovine brain. Eur. J. Biochem. 234 (1995) 786-793
5. Engelhardt J.I., Appel S.H., and Killian J.M. Experimental autoimmune motoneuron disease. Ann. Neurol. 26 (1989) 368-376
6. Hao Q., Saida T., Yoshino H., Kuroki S., Nukina M., and Saida K. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance. Ann. Neurol. 45 (1999) 758-768
7. Kaida K., Kusunoki S., Kamakura K., Motoyoshi K., and Kanazawa I. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GDla. Brain 123 (2000) 116-124
8. Kaida K., Kusunoki S., Kamakura K., Motoyoshi K., and Kanazawa I. GalNAc-GD1a in human peripheral nerve. Target sites of anti-ganglioside antibody. Neurology 61 (2003) 465-470
9. Koga M., Yuki N., Ariga T., Morimatsu M., and Hirata K. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?. J. Neuroimmunol. 86 (1998) 74-79
10. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
11. Matsumoto A., Yoshino H., Yuki N., Hara Y., Cashman N.R., Handa S., and Miyatake T. Ganglioside characterization of a cell line displaying motor neuron-like phenotype: GM2 as a possible major ganglioside in motor neurons. J. Neurol. Sci. 131 (1995) 111-118
12. Nagai K., Tadano-Aritomi K., Kawaguchi K., and Ishizuka I. Acidic glycolipids from dolphin kidney. J. Biochem. 98 (1985) 545-559
13. Odaka M., Yuki N., Yoshino H., Kasama T., Handa S., Irie F., Hirabayashi Y., Suzuki A., and Hirata K. N-glycolylneuraminic acid-containing GM1: a new molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 43 (1998) 829-834
14. Taguchi K., Ren J., Utsunomiya I., Aoyagi H., Fujita N., Ariga T., Miyatake T., and Yoshino H. Neurophysiological and immunohistochemical studies on Guillain-Barré syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission. J. Neurol. Sci. 225 (2004) 91-98
15. Willison H.J., and Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (2002) 2591-2625
16. Yoshino H., Miyashita. K., Miyatani N., Ariga T., Hashimoto Y., Tsuji S., Oyanagi K., Ohama E., Ikuta F., Suzuki A., and Miyatake T. Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis. J. Neurol. Sci. 97 (1990) 53-65
17. Yoshino H., Miyatani N., Saito M., Ariga T., Lugaresi A., Latov N., Kushi Y., Kasama T., and Yu R.K. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy. J. Neurochem. 59 (1992) 1684-1691
18. Yoshino H., Utsunomiya I., Taguchi K., Ariga T., Nagaoka T., Aoyagi H., Asano A., Yamada M., and Miyatake T. GalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal spinal roots. Brain Res. 1057 (2005) 177-180
19. Yu R.K., Itoh T., Yohe H.C., and Macala L.J. Characterization of some minor gangliosides in Tay-Sachs brains. Brain Res. 275 (1983) 47-52
20. Yu R.K., Yoshino H., Yamawaki M., Yoshino J.E., and Ariga T. Subcellular distribution of sulfatide glucuronyl glycolipids in human peripheral motor and sensory nerves, J. Biomed. Sci. 1 (1994) 167-171